Persones / Equip Humà

Jaume Català Mora

Buscador de publicacions

Publicacions

  • Padrón-Pérez N, Arias L, Rubio M, Lorenzo D, García-Bru P, Català-Mora J and Caminal JM.

    Changes in Choroidal Thickness After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy.

    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . 59(2): 1119-1124. Nº de cites: 34

    [doi:10.1167/iovs.17-22144]

  • Berdasco, M, Gomez, A, Rubio, MJ, Català-Mora J, Zanon-Moreno, V, Lopez, M, Hernandez, C, Yoshida, S, Nakama, T, Ishikawa, K, Ishibashi, T, Boubekeur, AM, Louhibi, L, Pujana, MA, Sayols, S, Setien, F, Corella, D, de Torres C, Parareda A, Mora J, Zhao, L, Zhang, K, Lleonart, ME, Alonso, J, Simo, R, Caminal, JM and Esteller, M.

    DNA Methylomes Reveal Biological Networks Involved in Human Eye Development, Functions and Associated Disorders

    SCIENTIFIC REPORTS . 7: 11762-11762. Nº de cites: 39

    [doi:10.1038/s41598-017-12084-1]

  • Català-Mora J, Cuadras-Palleja D, Díaz-Cascajosa J, Castany-Aregall M, Prat-Bartomeu J and García-Arumí J.

    Anterior iris-claw intraocular lens implantation for the management of nontraumatic ectopia lentis: long-term outcomes in a paediatric cohort.

    ACTA OPHTHALMOLOGICA . 95(2): 170-174. Nº de cites: 23

    [doi:10.1111/aos.13192]

  • Filloy A, Comas C and Català-Mora J.

    Anterior and Intermediate Uveitis with Retinal Vasculitis: An Unusual Manifestation of Post-Streptococcal Uveitis Syndrome

    OCULAR IMMUNOLOGY AND INFLAMMATION . 24(6): 607-609. Nº de cites: 6

    [doi:10.3109/09273948.2015.1094094]

  • Bonnet C, Riahi Z, Chantot-Bastaraud S, Smagghe L, Letexier M, Marcaillou C, Lefèvre GM, Hardelin JP, El-Amraoui A, Singh-Estivalet A, Mohand-Saïd S, Kohl S, Kurtenbach A, Sliesoraityte I, Zobor D, Gherbi S, Testa F, Simonelli F, Banfi S, Fakin A, Glavac D, Jarc-Vidmar M, Zupan A, Battelino S, Martorell-Sampol L, Clavería MA, Català-Mora J, Dad S, Møller LB, Jesus Rodriguez Jorge, Hawlina M, Auricchio A, Sahel JA, Marlin S, Zrenner E, Audo I and Petit C.

    An innovative strategy for the molecular diagnosis of Usher syndrome identifies causal biallelic mutations in 93% of European patients

    EUROPEAN JOURNAL OF HUMAN GENETICS . 24(12): 1730-1738. Nº de cites: 79

    [doi:10.1038/ejhg.2016.99]

  • Pascual-Pastó G, Gene-Olaciregui N, Vilà-Ubach M, Paco-Mercader S, Monterrubio C, Rodriguez E, Winter U, Batalla-Vilacís M, Català-Mora J, Salvador-Hernandez H, Parareda A, Schaiquevich P, Suñol M, Mora J, Lavarino C, de Torres C, Chantada G and Carcaboso AM.

    Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination

    CANCER LETTERS . 380(1): 10-19. Nº de cites: 25

    [doi:10.1016/j.canlet.2016.06.012]

  • Llorca-Cardeñosa A, Català-Mora J, Garcia-Cazorla A, Meavilla-Olivas SM and Castejón-Ponce E.

    Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: A case report.

    Archivos De La Sociedad Española De Oftalmología . 91(5): 236-239.

    [doi:10.1016/j.oftal.2016.01.006]

  • Jurado-Guano N, Català-Mora J and Suñol M.

    Incontinentia pigmenti: a propósito de un caso

    Annals d'Oftalmologia . 24(1): 32-36.

  • Yeste-Mayoral B, Fresno-Cañada C, Puigventós E, Jimenez E, Suh S, Ayet I and Català-Mora J.

    Evaluación y tratamiento de la ambliopía

    Annals d'Oftalmologia . 23(2): .

  • Grigorovski N, Lucena E, Mattosinho C, Parareda A, Ferman S, Català-Mora J and Chantada G.

    Use of intra-arterial chemotherapy for retinoblastoma: results of a survey

    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY . 7(4): 726-730. Nº de cites: 42

    [doi:10.3980/j.issn.2222-3959.2014.04.26]